Why Did Petros Pharmaceuticals, Inc. (PTPI) Soar 32.76% in Pre-Market Trading?

On March 26, 2025, Petros Pharmaceuticals, Inc. Common Stock (PTPI) surged 32.76% in pre-market trading, indicating a significant bullish sentiment among investors.

Petros Pharmaceuticals, Inc. (PTPI) has been experiencing a volatile period, with its stock price declining by 18.31% during Tuesday's pre-market session, reaching $0.06. This decline comes after a 39.57% drop in the past month, reflecting ongoing challenges faced by the company. However, the stock showed a positive after-hours movement, recording a 14.19% increase, reaching $0.07. This after-hours surge suggests that investors may be finding value in the stock despite recent setbacks.

The company's short interest ratio, which stands at 3.52% of the float, indicates a moderate level of bearish sentiment among traders. This ratio represents the number of shares sold short divided by the float, or the number of shares available for trading by the public. A higher short interest ratio can signal that traders are betting against the stock, but it can also present an opportunity for a short squeeze if the stock price rises.